295 related articles for article (PubMed ID: 9582553)
1. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, determinants, and clinical significance of hyperhomocyst(e)inaemia in renal-transplant recipients.
Ducloux D; Ruedin C; Gibey R; Vautrin P; Bresson-Vautrin C; Rebibou JM; Chalopin JM
Nephrol Dial Transplant; 1998 Nov; 13(11):2890-3. PubMed ID: 9829496
[TBL] [Abstract][Full Text] [Related]
4. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocyst(e)inemia in chronic stable renal transplant patients.
Machado DJ; Paula FJ; Sabbaga E; Ianhez LE
Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(5):161-8. PubMed ID: 11175576
[TBL] [Abstract][Full Text] [Related]
7. Elevated homocyst(e)ine levels with preeclampsia.
Rajkovic A; Catalano PM; Malinow MR
Obstet Gynecol; 1997 Aug; 90(2):168-71. PubMed ID: 9241286
[TBL] [Abstract][Full Text] [Related]
8. Homocyst(e)ine, vitamins and genetic interactions in vascular disease.
Malinow MR
Can J Cardiol; 1999 Apr; 15 Suppl B():31B-34B. PubMed ID: 10350683
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia--determining factors and treatment.
Genest J
Can J Cardiol; 1999 Apr; 15 Suppl B():35B-38B. PubMed ID: 10350684
[TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine levels in renal transplant patients on tacrolimus therapy.
Akbas SH; Tuncer M; Gurkan A; Yucetin L; Yavuz A; Demirbas A; Ersoy F; Gultekin M; Yakupoglu G; Akaydin M
Transplant Proc; 2004; 36(1):159-60. PubMed ID: 15013332
[TBL] [Abstract][Full Text] [Related]
11. Influence of folic acid, pyridoxal phosphate and cobalamin on plasma homocyst(e)ine levels and the susceptibility of low-density lipoprotein to ex-vivo oxidation.
Weiss N; Feussner A; Hailer S; Spengel FA; Keller C; Wolfram G
Eur J Med Res; 1999 Oct; 4(10):425-32. PubMed ID: 10527956
[TBL] [Abstract][Full Text] [Related]
12. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease.
Malinow MR; Duell PB; Hess DL; Anderson PH; Kruger WD; Phillipson BE; Gluckman RA; Block PC; Upson BM
N Engl J Med; 1998 Apr; 338(15):1009-15. PubMed ID: 9535664
[TBL] [Abstract][Full Text] [Related]
13. Reduced total plasma homocyst(e)ine in children and adolescents with type 1 diabetes.
Wiltshire E; Thomas DW; Baghurst P; Couper J
J Pediatr; 2001 Jun; 138(6):888-93. PubMed ID: 11391334
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.
Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC
Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698
[TBL] [Abstract][Full Text] [Related]
15. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
[TBL] [Abstract][Full Text] [Related]
16. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
[TBL] [Abstract][Full Text] [Related]
17. Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background.
Moghadasian MH; McManus BM; Frohlich JJ
Arch Intern Med; 1997 Nov; 157(20):2299-308. PubMed ID: 9361570
[TBL] [Abstract][Full Text] [Related]
18. Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia.
Manns B; Hyndman E; Burgess E; Parsons H; Schaefer J; Snyder F; Scott-Douglas N
Kidney Int; 2001 Mar; 59(3):1103-9. PubMed ID: 11231366
[TBL] [Abstract][Full Text] [Related]
19. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
Sydow K; Böger RH
Z Kardiol; 2001 Jan; 90(1):1-11. PubMed ID: 11220081
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocyst(e)inemia: is this a novel risk factor in hypertension?
Virdis A; Ghiadoni L; Salvetti G; Versari D; Taddei S; Salvett A
J Nephrol; 2002; 15(4):414-21. PubMed ID: 12243373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
